Subscribe to Newsletter

Rapid Analysis of Nitrosamines in Drug Product Using SIFT-MS


The presence of nitrosamines in drug products is a continuing challenge for the pharmaceutical industry (EMA (2021); US FDA (2021)). Golob et al. (2022) have provided an excellent, up-to-date overview of the history. A method for quantitation of N-nitrosodimethylamine (NDMA) direct from drug products using headspace- selected ion flow tube mass spectrometry (SIFT-MS) was described in a recent application note (Perkins and Langford (2022a)). There, two ranitidine drug products were used as part of method development. Although these were not from a recalled batch to the best of our knowledge, NDMA concentrations of 68 and 328 ng g-1, respectively, were detected.

Read the full article now

Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE!

Receive content, products, events as well as relevant industry updates from The Analytical Scientist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Analytical Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Analytical Scientist magazine